Bandy Barton P. 4
4 · ReShape Lifesciences Inc. · Filed Nov 16, 2021
Insider Transaction Report
Form 4
Bandy Barton P.
DirectorPresident and CEO
Transactions
- Sale
Common Stock, $0.001 par value per share
2021-11-02$2.69/sh−13,505$36,328→ 865,442 total
Footnotes (1)
- [F1]These shares were sold to cover taxes in connection with the vesting of restricted stock units.